Clinical Benefits of Oral Anticoagulants for Elderly Patients With Cardioembolic Stroke at High Bleeding Risk

The relationship between the severity of cardioembolic stroke (CES) and oral anticoagulant (OAC) treatment before stroke onset in very elderly (≥80 years) patients with nonvalvular atrial fibrillation (NVAF) at high bleeding risk remains unknown. A total of 364 consecutive patients (≥80 years) with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	In vivo (Athens) 2024-03, Vol.38 (2), p.725-733
Hauptverfasser:	Saito, Kazumasa, Hagii, Joji, Soma, Takanobu, Washima, Shota, Yamada, Natsumi, Shiroto, Hiroshi, Saito, Shin, Kamada, Takaatsu, Takanashi, Shingo, Tomita, Hirofumi
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aged Anticoagulants - adverse effects Atrial Fibrillation - complications Atrial Fibrillation - drug therapy Embolic Stroke - chemically induced Embolic Stroke - complications Embolic Stroke - drug therapy Hemorrhage - drug therapy Hemorrhage - etiology Humans Retrospective Studies Risk Factors Stroke - diagnosis Stroke - drug therapy Stroke - etiology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!